CSat Investment Advisory’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $25K | Sell |
163
-19
| -10% | -$2.91K | 0.02% | 342 |
|
|
2020
Q4 | $28K | Sell |
182
-4,318
| -96% | -$664K | 0.03% | 281 |
|
|
2020
Q3 | $515K | Sell |
4,500
-531
| -11% | -$60.8K | 0.05% | 177 |
|
|
2020
Q2 | $565K | Buy |
5,031
+2,962
| +143% | +$333K | 0.07% | 163 |
|
|
2020
Q1 | $185K | Buy |
2,069
+220
| +12% | +$19.7K | 0.04% | 250 |
|
|
2019
Q4 | $200K | Buy |
1,849
+972
| +111% | +$105K | 0.05% | 232 |
|
|
2019
Q3 | $86K | Buy |
877
+130
| +17% | +$12.7K | 0.03% | 348 |
|
|
2019
Q2 | $98K | Buy |
747
+668
| +846% | +$87.6K | 0.03% | 299 |
|
|
2019
Q1 | $11K | Sell |
79
-16
| -17% | -$2.23K | 0.01% | 425 |
|
|
2018
Q4 | $9K | Buy |
95
+28
| +42% | +$2.65K | 0.01% | 430 |
|
|
2018
Q3 | $9K | Buy |
67
+11
| +20% | +$1.48K | 0.01% | 395 |
|
|
2018
Q2 | $7K | Buy |
+56
| New | +$7K | ﹤0.01% | 425 |
|